Video
Dr. Miller: “No limits” to what HoLEP can offer appropriate patients with BPH
Author(s):
“We're doing probably one of the highest volume of HoLEP cases…in the United States,” says Nicole L. Miller, MD, FACS.
Video Player is loading.
In this video, Nicole L. Miller, MD, FACS, discusses what sets her HoLEP practice for treating patients with benign prostatic hyperplasia from other centers. Miller is a professor of urology and fellowship director, Endourology and Laparoscopic Surgery, at Vanderbilt University Medical Center in Nashville, Tennessee.
Related Videos
Alexander Glaser, MD, on real-world outcomes with Aquablation
Vitaly Margulis, MD, on preliminary safety, efficacy of padeliporfin VTP for UTUC
Clinical Benefits of BPH Treatments
Joseph Jacob, MD, on the durability of TAR-200 in NMIBC
John Gore, MD, on radical cystectomy vs bladder-sparing therapy for NMIBC
Jason Hafron, MD, outlines AUA 2025 session on clinical trial recruitment
Study data point to gender disparities in oncology research citations
Matthew Galsky, MD, on patient selection for perioperative durvalumab/chemo in MIBC
Ekene Enemchukwu, MD, on guideline-associated trends in OAB therapy use
Nitin Yerram, MD, highlights trial of 177Lu-PSMA-617 in localized prostate cancer
Related Content
